Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

Chemokine receptor modulators in early development at AstraZeneca

April 5, 2000

First phase II clinical trial of ABX-IL-8 begins in psoriasis

April 5, 2000

Draxis seeks approval of Levulan PDT in Canada

March 31, 2000

Organogenesis receives milestone payment related to Apligraf progress

March 30, 2000

TRK-820 demonstrates kappa-receptor-mediated antipruritic effects in animal model

March 29, 2000

SkyePharma and Bioglan establish marketing agreement for Solarase

March 23, 2000

FDA approves modifications to Dermagraft IDE for diabetic foot ulcers

March 23, 2000

Pharmadigm reports phase II results for DHEAS in burn patients

March 22, 2000

Chrysalin accelerates fracture healing in preclinical animal studies

March 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...